Legal & General Group PLC Ardelyx, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 259,668 shares of ARDX stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259,668

Previous 234,835 10.57%

Holding current value

$1.67 Million

Previous $1.71 Million 12.25%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $146,266 - $231,195	24,833 Added 10.57%	259,668 $1.92 Million
Q1 2024 May 14, 2024	BUY	$6.05 - $9.74 $88,317 - $142,184	14,598 Added 6.63%	234,835 $1.71 Million
Q4 2023 Feb 15, 2024	BUY	$3.29 - $6.64 $73,765 - $148,875	22,421 Added 11.33%	220,237 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$3.3 - $4.83 $5,903 - $8,640	-1,789 Reduced 0.9%	197,816 $807,000
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $472,742 - $724,482	146,360 Added 274.88%	199,605 $676,000
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $142,696 - $255,043	53,245 New	53,245 $255,000
Q2 2022 Aug 22, 2022	SELL	$0.51 - $1.17 $4,259 - $9,770	-8,351 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $81,312 - $160,733	-94,549 Reduced 91.88%	8,351 $9,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $116,937 - $752,269	92,077 Added 850.75%	102,900 $136,000
Q2 2021 Aug 12, 2021	SELL	$6.55 - $8.98 $1,650 - $2,262	-252 Reduced 2.28%	10,823 $82,000
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $2,519 - $3,175	-413 Reduced 3.6%	11,075 $73,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $16,002 - $21,579	-3,048 Reduced 20.97%	11,488 $60,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $36,150 - $54,596	6,732 Added 86.26%	14,536 $100,000
Q1 2020 May 14, 2020	SELL	$4.35 - $8.79 $1,592 - $3,217	-366 Reduced 4.48%	7,804 $44,000
Q3 2019 Nov 13, 2019	BUY	$2.15 - $6.28 $3,412 - $9,966	1,587 Added 24.11%	8,170 $38,000
Q3 2018 Nov 20, 2018	BUY	$3.75 - $4.65 $7,470 - $9,262	1,992 Added 43.39%	6,583 $29,000
Q2 2018 Aug 10, 2018	SELL	$3.7 - $5.8 $7,048 - $11,049	-1,905 Reduced 29.33%	4,591 $17,000
Q1 2018 May 17, 2018	SELL	$5.05 - $7.9 $12,816 - $20,050	-2,538 Reduced 28.09%	6,496 $33,000
Q4 2017 Feb 13, 2018	BUY	$4.85 - $7.8 $43,814 - $70,465	9,034	9,034 $60,000

Others Institutions Holding ARDX

# of Institutions

209

Shares Held

144M

Call Options Held

1.01M

Put Options Held

1.43M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $994M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Ardelyx, Inc. Transaction History